Ganjapreneur report

In the midst of the hostile takeover attempt by Aurora Cannabis, CanniMed Therapeutics has adopted a shareholder rights plan – or “poison pill” – preventing Aurora from buying more shares or entering in any new lock-up agreements with current shareholders.

According to a press release, the purpose of the plan is to ensure CanniMed shareholders are not subject to coercive bids and allow them to vote on the proposed acquisition of medical cannabis producer Newstrike Resources. Aurora’s bid requires the Newstrike deal – which offers 33 CanniMed shares for every 1,000 Newstrike shares – to be terminated.

Full article

CanniMed Takes ‘Poison Pill’ in Attempt to Thwart Aurora Takeover